ImmunoGen (IMGN) Stock Forecast for 2024–2028. Sell or Buy Prediction







Maximizing Profits: When is the Right Time to Sell Your Business?

April 23, 2024 Maximizing Profits: When is the Right Time to Sell Your Business?

Selling a business can be a momentous decision filled with many considerations and uncertainties. As an entrepreneur, this also symbolizes your years of…
Improve Your Financial Status: A How-To Guide

April 12, 2024 Improve Your Financial Status: A How-To Guide

Navigating through the complexities of personal finance can often feel like walking through a maze blindfolded. This guide is crafted especially for you,…
How ZIM Integrated Container Tracking is Revolutionizing Global Trade

April 12, 2024 How ZIM Integrated Container Tracking is Revolutionizing Global Trade

Have you ever wondered how your online shopping packages get to you? A big part of the answer is ZIM Integrated Container Tracking.…
6 Best Growth Stocks To Buy Now According to Metatrader 5

March 15, 2024 6 Best Growth Stocks To Buy Now According to Metatrader 5

One of the reasons investors prefer growth stocks is that they are expected to perform better than other companies in terms of sales…

ImmunoGen (IMGN) Stock Forecast for 2024–2028. Sell or Buy?

Updated: June 23, 2024 (02:35)

Sector: Healthcare

The share price of ImmunoGen, Inc. (IMGN) now

This company is DELISTED
Latest session on the 26th of February for
ImmunoGen, Inc. is negative
Trading Volume: 40
Open: 31.23 /  High: 31.23 /  Low: 31.23
What analysts predict: $
52-week High/Low: $ / $

50/200 Day Moving Average: $ / $

This figure corresponds to the Average Price over the previous 50/200 days. For ImmunoGen stocks, the 50-day moving average is the support level today.

For ImmunoGen stocks, the 200-day moving average is the support level today.

Are you interested in ImmunoGen, Inc. stocks and want to buy them, or are they already in your portfolio? If yes, then on this page you will find useful information about the dynamics of the ImmunoGen stock price in 2024, 2025, 2026, 2027, 2028. How much will one ImmunoGen share be worth in 2024 - 2028?

When should I take profit in ImmunoGen stock? When should I record a loss on ImmunoGen stock? What are analysts' forecasts for ImmunoGen stock? What is the future of ImmunoGen stock? We forecast ImmunoGen stock performance using neural networks based on historical data on ImmunoGen stocks. Also, when forecasting, technical analysis tools are used, world geopolitical and news factors are taken into account.

ImmunoGen stock prediction results are shown below and presented in the form of graphs, tables and text information, divided into time intervals. (Next month, 2024, 2025, 2026, 2027 and 2028) The final quotes of the instrument at the close of the previous trading day are a signal to adjust the forecasts for ImmunoGen shares. This happens once a day.


Historical and forecast chart of ImmunoGen stock

The chart below shows the historical price of ImmunoGen stock and a prediction chart for the next month. For convenience, prices are divided by color. Forecast prices include: Optimistic Forecast, Pessimistic Forecast, and Weighted Average Best Forecast. Detailed values for the ImmunoGen stock price can be found in the table below.

No data

Long-term forecasts by years.

ImmunoGen, Inc., a clinical-stage biotechnology company, is developing antibody-drug conjugate (ADC) therapies for cancer. Its candidate products include mirvetuximab soravtansine, an alpha-folate receptor-targeted ADC that is in phase III clinical trials for the treatment of platinum-resistant ovarian cancer; and IMGN632, an ADC targeting CD123, which is in phase I clinical trials for the treatment of AML and blast plasmacytoid dendritic cell neoplasms.

ImmunoGen daily forecast for a month

Date Target Pes. Opt. Vol., %
Jun 24 30.94 30.62 31.29 2.18
Jun 25 31.24 31.01 31.70 2.24
Jun 26 31.48 31.29 31.79 1.61
Jun 27 31.07 30.74 31.31 1.86
Jun 28 31.47 30.97 31.85 2.85
Jun 29 31.79 31.46 32.12 2.10
Jun 30 31.48 31.28 31.72 1.41
Jul 01 31.44 31.31 31.66 1.15
Jul 02 31.09 30.91 31.58 2.17
Jul 03 30.96 30.64 31.32 2.22
Jul 04 31.07 30.63 31.40 2.52
Jul 05 31.64 31.35 31.97 1.96
Jul 06 31.99 31.50 32.49 3.15
Jul 07 32.47 32.17 32.97 2.48
Jul 08 32.63 32.22 32.80 1.80
Jul 09 32.58 32.43 32.78 1.08
Jul 10 33.01 32.60 33.24 1.96
Jul 11 33.59 33.31 33.94 1.90
Jul 12 33.82 33.65 33.96 0.94
Jul 13 33.51 33.12 33.87 2.25
Jul 14 33.60 33.34 33.94 1.79
Jul 15 33.12 32.74 33.30 1.72
Jul 16 33.66 33.13 34.08 2.89
Jul 17 33.36 33.21 33.87 1.99
Jul 18 33.80 33.55 34.32 2.32
Jul 19 34.00 33.55 34.49 2.82
Jul 20 33.54 33.39 33.73 1.02
Jul 21 33.33 32.91 33.68 2.35
Jul 22 33.01 32.65 33.21 1.72
Jul 23 33.25 32.85 33.44 1.78

ImmunoGen Daily Price Targets


ImmunoGen Stock Forecast 06-24-2024.

Forecast target price for 06-24-2024: $30.94.
Negative dynamics for ImmunoGen shares will prevail with possible volatility of 2.136%.
Pessimistic target level: 30.62
Optimistic target level: 31.29

ImmunoGen Stock Forecast 06-25-2024.

Forecast target price for 06-25-2024: $31.24.
Positive dynamics for ImmunoGen shares will prevail with possible volatility of 2.188%.
Pessimistic target level: 31.01
Optimistic target level: 31.70

ImmunoGen Stock Forecast 06-26-2024.

Forecast target price for 06-26-2024: $31.48.
Positive dynamics for ImmunoGen shares will prevail with possible volatility of 1.584%.
Pessimistic target level: 31.29
Optimistic target level: 31.79

ImmunoGen Stock Forecast 06-27-2024.

Forecast target price for 06-27-2024: $31.07.
Negative dynamics for ImmunoGen shares will prevail with possible volatility of 1.826%.
Pessimistic target level: 30.74
Optimistic target level: 31.31

ImmunoGen Stock Forecast 06-28-2024.

Forecast target price for 06-28-2024: $31.47.
Positive dynamics for ImmunoGen shares will prevail with possible volatility of 2.767%.
Pessimistic target level: 30.97
Optimistic target level: 31.85

ImmunoGen Stock Forecast 06-29-2024.

Forecast target price for 06-29-2024: $31.79.
Positive dynamics for ImmunoGen shares will prevail with possible volatility of 2.059%.
Pessimistic target level: 31.46
Optimistic target level: 32.12

IMGN (IMGN) Monthly Stock Prediction for 2024

Month Target Pes. Opt. Vol., %
Jul. 29.08 26.28 31.04 15.32
Aug. 28.25 25.45 30.24 15.83
Sep. 28.71 27.21 31.25 12.95
Oct. 24.92 23.58 27.69 14.85
Nov. 22.90 20.60 24.42 15.62
Dec. 23.28 22.02 24.47 9.99

ImmunoGen forecast for this year


ImmunoGen Stock Prediction for Jul 2024

An downtrend is forecast for this month with an optimal target price of $29.0751. Pessimistic: $26.28. Optimistic: $31.04


ImmunoGen Stock Prediction for Aug 2024

An downtrend is forecast for this month with an optimal target price of $28.2465. Pessimistic: $25.45. Optimistic: $30.24


ImmunoGen Stock Prediction for Sep 2024

An uptrend is forecast for this month with an optimal target price of $28.7126. Pessimistic: $27.21. Optimistic: $31.25


ImmunoGen Stock Prediction for Oct 2024

An downtrend is forecast for this month with an optimal target price of $24.9225. Pessimistic: $23.58. Optimistic: $27.69


ImmunoGen Stock Prediction for Nov 2024

An downtrend is forecast for this month with an optimal target price of $22.9038. Pessimistic: $20.60. Optimistic: $24.42


ImmunoGen Stock Prediction for Dec 2024

An uptrend is forecast for this month with an optimal target price of $23.2817. Pessimistic: $22.02. Optimistic: $24.47



ImmunoGen (IMGN) Monthly Stock Prediction for 2025

Month Target Pes. Opt. Vol., %
Jan 22.23 21.53 23.70 9.15
Feb 21.43 19.86 23.94 17.05
Mar 23.01 22.15 25.22 12.18
Apr 25.18 23.56 26.62 11.49
May 24.31 22.20 25.96 14.47
Jun 21.94 19.84 24.02 17.41
Jul 22.67 20.53 23.42 12.34
Aug 24.67 23.64 25.86 8.59
Sep 24.86 23.37 27.54 15.16
Oct 26.95 23.75 28.36 16.25
Nov 27.76 26.88 28.88 6.92
Dec 30.92 28.55 32.26 11.50

ImmunoGen (IMGN) Monthly Stock Prediction for 2026

Month Target Pes. Opt. Vol., %
Jan 33.33 29.38 36.03 18.46
Feb 30.73 29.16 33.87 13.88
Mar 27.23 24.94 28.45 12.34
Apr 26.94 25.53 30.18 15.40
May 27.27 24.85 29.84 16.72
Jun 28.00 26.07 29.81 12.54
Jul 30.82 29.75 33.91 12.27
Aug 34.14 32.10 36.50 12.07
Sep 31.63 28.12 34.62 18.78
Oct 30.73 29.44 32.72 10.00
Nov 29.12 26.54 32.05 17.17
Dec 27.55 25.07 30.44 17.65

ImmunoGen (IMGN) Monthly Stock Prediction for 2027

Month Target Pes. Opt. Vol., %
Jan 27.42 26.23 29.60 11.39
Feb 27.51 24.86 28.95 14.11
Mar 25.86 23.92 26.98 11.36
Apr 26.51 24.80 28.26 12.24
May 27.35 26.45 29.93 11.65
Jun 28.25 26.26 29.52 11.05
Jul 29.48 26.96 30.45 11.47
Aug 32.00 30.90 34.31 9.93
Sep 33.35 32.30 34.35 5.97
Oct 32.00 28.30 33.72 16.08
Nov 27.72 24.56 30.72 20.04
Dec 27.22 25.55 28.86 11.46

ImmunoGen (IMGN) Monthly Stock Prediction for 2028

Month Target Pes. Opt. Vol., %
Jan 26.90 25.28 29.36 13.88
Feb 27.46 26.60 29.73 10.53
Mar 30.76 27.71 33.71 17.79
Apr 33.57 30.20 36.19 16.56
May 31.21 28.40 33.36 14.87
Jun 29.85 26.27 32.22 18.48
Jul 34.19 31.78 35.83 11.31
Aug 36.24 33.74 38.31 11.92
Sep 34.12 30.23 36.07 16.18
Oct 34.43 32.52 36.50 10.90
Nov 34.53 33.19 36.04 7.91
Dec 29.46 26.76 31.18 14.17

ImmunoGen information and performance

ImmunoGen Address

N/A

Market Capitalization: N/A $

Market capitalization of the ImmunoGen, Inc. is the total market value of all issued shares of a company. It is calculated by the formula multiplying the number of IMGN shares in the company outstanding by the market price of one share.

EBITDA: N/A $

EBITDA of ImmunoGen is earnings before interest, income tax and depreciation of assets.

PE Ratio: N/A

P/E ratio (price to earnings) - shows the ratio between the price of a share and the company's profit

PEG Ratio: N/A

Price/earnings to growth

DPS: N/A

Dividend Per Share is a financial indicator equal to the ratio of the company's net profit available for distribution to the annual average of ordinary shares.

DY: N/A

Dividend yield is a ratio that shows how much a company pays in dividends each year at the stock price.

EPS: N/A

EPS shows how much of the net profit is accounted for by the common share.

Quarterly Earnings Growth YOY: N/A
Quarterly Revenue Growth YOY: N/A
Trailing PE: N/A

Trailing P/E depends on what has already been done. It uses the current share price and divides it by the total earnings per share for the last 12 months.

Forward PE: N/A

Forward P/E uses projections of future earnings instead of final numbers.

EV To Revenue: N/A

Enterprise Value (EV) /Revenue

EV To EBITDA: N/A

The EV / EBITDA ratio shows the ratio of the cost (EV) to its profit before tax, interest and amortization (EBITDA).

Shares Outstanding: N/A

Number of issued ordinary shares

Shares Float: N/A

Number of freely tradable shares

Shares Short Prior Month: N/A

Shares Short Prior Month - the number of shares in short positions in the last month.

Short Ratio: N/A
Percent Insiders: N/A
Percent Institutions: N/A



Related stocks from Healthcare sector


Disclaimer:

All forecast data on the site are provided for informational purposes of using neural forecasting tools in the financial market and are not a call to action and, moreover, are not trading signals. When using the forecast data, the investor assumes all financial risks. The pandaforecast.com portal is not responsible for the loss of your money in the stock market as a result of using the information contained on the site.